A phase I/IIa study of CAN-04 for the treatment of non-small cell lung cancer and pancreatic cancer.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs CAN 04 (Primary)
- Indications Non-small cell lung cancer; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CANFOUR
- 21 Jul 2017 According to a Cantargia media release, clinical trial application for this trial has been approved by the regulatory authorities as well as the ethics committees in Denmark and Norway. The review is ongoing in additional countries.
- 08 May 2017 This trial is expected to begin in June 2017, according to a Cantargia media release.
- 20 Sep 2016 According to Cantargia media release, presentation of the phase I data is planned about a year after the start of the study.